RB
Robert Bruce (Bruce & Co) disclosed reduced in Kodiak Sciences
Robert Bruce (Bruce & Co) filed a 13F change in Kodiak Sciences (50015M109) on 2025-05-14, covering period end 2025-03-31.
Action
Reduced
Capital
$907,630 current disclosed value
Institutional 13F Signals1 evidence source
Why it matters
This signal is selected by portfolio impact within the manager filing, while the full filing change list remains available in the briefing.
Full Filing Changes
41 changes from Robert Bruce (Bruce & Co), filed 2025-05-14 for period end 2025-03-31.
$311.8M portfolio value
| Stock | Action | Change | Current | Portfolio Impact |
|---|---|---|---|---|
N00985106 AerCap Holdings | Increased | $4.4M | $18.7M | 1.41% |
23586506 Uhaul B | Reduced | -$3.2M | $26.7M | 1.01% |
589331107 Merck | Reduced | -$3.0M | $18.2M | 0.95% |
163851108 Chemours | New | $2.7M | $2.7M | 0.87% |
50015M109 Kodiak Sciences | Reduced | -$2.3M | $907,630 | 0.74% |
00287Y109 Abbvie | Increased | $2.3M | $26.7M | 0.73% |
125896100 CMS Energy | Reduced | -$2.1M | $17.0M | 0.67% |
00206R102 AT & T | Increased | $1.4M | $19.0M | 0.46% |
651639106 Newmont | Increased | $1.1M | $4.8M | 0.35% |
37833100 Apple | Reduced | -$1.1M | $8.6M | 0.35% |
05379B107 Avista | Increased | $1.1M | $8.4M | 0.34% |
92333F101 Venture Global | New | $1.0M | $1.0M | 0.33% |
2824100 Abbott | Increased | $974,357 | $17.7M | 0.31% |
20002101 Allstate | Increased | $828,190 | $26.0M | 0.27% |
98389B100 XEL Energy | Increased | $636,015 | $13.8M | 0.20% |
71535D106 Personalis | Reduced | -$574,310 | $888,030 | 0.18% |
449585108 IGM Bioscience | Reduced | -$496,000 | $115,000 | 0.16% |
26441C204 Duke Energy | Increased | $347,062 | $21.4M | 0.11% |
237266101 Darling Ingredients | Reduced | -$345,450 | $4.4M | 0.11% |
717081103 Pfizer | Reduced | -$323,561 | $6.9M | 0.10% |
868459108 Supernus | Reduced | -$279,978 | $2.7M | 0.09% |
23586100 Uhaul | Reduced | -$275,647 | $4.8M | 0.09% |
56400P706 Mannkind | Reduced | -$273,102 | $981,217 | 0.09% |
91911K102 Bausch Health | Reduced | -$271,890 | $1.1M | 0.09% |
302571104 Nextera Energy | Reduced | -$252,000 | $22.3M | 0.08% |
39483102 Archer Daniels | Reduced | -$251,000 | $4.8M | 0.08% |
45774W108 Insteel | Reduced | -$243,830 | $9.0M | 0.08% |
92556V106 Viatris | Reduced | -$217,964 | $507,610 | 0.07% |
00484MAB2 Acorda Theraputics | Sold out | -$200,000 | $0 | 0.06% |
44209104 Ashland | Reduced | -$182,550 | $889,350 | 0.06% |
142038108 Caribou Biosciences | Reduced | -$170,000 | $227,500 | 0.05% |
65443P102 908 Devices | Increased | $155,692 | $305,921 | 0.05% |
31189P102 Fate Theraputics | Reduced | -$143,000 | $434,500 | 0.05% |
268311107 EDAP | Reduced | -$138,413 | $1.1M | 0.04% |
532457108 Eli Lilly | Increased | $107,820 | $1.7M | 0.03% |
925815102 Vicor | Reduced | -$107,800 | $3.3M | 0.03% |
H11356104 Bunge | Reduced | -$107,200 | $6.1M | 0.03% |
749607107 RLI | Reduced | -$85,068 | $3.3M | 0.03% |
N51517105 Lava Theraputics | Reduced | -$70,500 | $662,780 | 0.02% |
82968B103 XM Sirius | Reduced | -$16,556 | $1.3M | 0.01% |
68622V106 Organon | Reduced | -$936 | $464,568 | 0.00% |